Continuous Glucose Monitoring of Hospitalized Patients With Diabetes

NAActive, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 20, 2021

Primary Completion Date

September 30, 2024

Study Completion Date

December 31, 2024

Conditions
DiabetesDiabetes MellitusGlucose, High BloodGlucose, Low Blood
Interventions
DEVICE

Dexcom Generation 6 CGM (Dexcom Gen6) device

Standing orders for blood sugars less than 100 will allow for administration of glucose replacement in the intervention group based on Dexcom Gen6 readings.

Trial Locations (1)

76508

Baylor Scott & White Medical Center - Temple, Temple

Sponsors
All Listed Sponsors
lead

Baylor Research Institute

OTHER